The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke

Brain Research

Volumn 574, Issue 1-2, 1992, Pages 171-177

  Buchan, Alastair M ^a,b   Slivka, Andrew ^c   Xue, Dong ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Cerebral blood flow; Dizocilipine maleate (MK 801); Infarct volume; N Methyl d aspartate receptor; Spontaneously hypertensive rat; Stroke model, focal

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE;

ANIMAL; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; DIZOCILPINE MALEATE; ISCHEMIC ATTACK, TRANSIENT; MALE; RATS; RATS, INBRED STRAINS; RECEPTORS, N-METHYL-D-ASPARTATE; SUPPORT, NON-U.S. GOV'T;

EID: 0026522027     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(92)90814-P     Document Type: Article

References (39)

1. Absence of N-methyl-d-aspartate receptors on ovine cerebral microvessels
2. Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
3. Hypothermia but not the N-methyl-d-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia
4. The N-methyl-d-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe, forebrain ischemia in adult rats
5. MK-801 increases cerebral blood flow in a rat model of temporary focal cortical ischemia
6. Pre- and posttreatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat
7. Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model
8. A glutamate antagonist reduces infarction size following focal cerebral ischemia independently of vascular and metabolic changes
9. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo
10. Kynurenate inhibition of cell excitation decreases stroke size and deficits
11. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil
12. Excitatory amino acids and cerebrovascular tone
13. MK-801 increases CBF in moderately ischemic rat cortex
14. Dextrorphan reduces infarct volume after middle cerebral occlusion in rats: a magnetic resonance imaging and histopathology study
15. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia
16. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetized with halothane
17. The effects of NMDA receptor blockade with MK-801 upon relationship between cerebral blood flow and glucose utilisation
18. Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat
19. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat
20. Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia
21. Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat
22. The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: modification by prior complete cerebral ischemia
23. N-Methyl-d-aspartate antagonist reduces stroke size and regional glucose metabolism
24. Blockade of the NMDA receptors may protect against ischemic damage in the brain
25. Repeated measurements of cerebral blood flow in rats. Comparison between the hydrogen clearance method and laser Doppler flowmetry
26. Effect of antihypertensive therapy on focal stroke in spontaneously hypertensive rats
27. Effects of halothane on regional cerebral blood flow in experimental focal ischemia
28. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits
29. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia
30. Protective effect of N-methyl-d-aspartate antagonists after local cerebral ischemia in rabbits
31. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia
32. Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoic acid in a rat model of incomplete forebrain ischemia
33. The effects of a competitive NMDA receptor antagonist (CGS19755) on cerebral pH and blood flow in focal ischemia
34. In vivo and in vitro effects of the NMDA receptor antagonist dizocilipine (MK-801) on the cerebrovascular bed of the goat
35. Dextromethorphan attenuates post-ischemic hypoperfusion following incomplete global ischemia in the anaesthetized rat
36. The NMDA antagonist, MK-801 is cerebro-protective in situations where some energy production prevails but not under conditions of complete energy deprivation
37. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo (F) quinoxaline: a neuroprotectant for cerebral ischemia
38. 1 hippocampal injury following severe but transient forebrain ischemia in adult rats
39. Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia